PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

I think most would say it was sold off too much at this stage...

  1. 773 Posts.
    lightbulb Created with Sketch. 220
    I think most would say it was sold off too much at this stage despite questions around capital. Perhaps that issue is now less of an issue once Marco came on board and they clarified at least a couple of options going forward. I have a theory, given the strong US dollar, perhaps US buyers are looking at O/S markets for some great discount buying? Tie that in with Marco and perhaps he has already made some contacts in the US who are buying?? Whatever it's great to see and look forward to a positive update soon to keep the momemtum. GLTA
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.